Cargando…

Cured of Primary Bone Cancer, But at What Cost: A Qualitative Study of Functional Impairment and Lost Opportunities

Purpose. Our study aims to explore how former cancer patients experience physical and psychosocial late effects 3–7 years after they underwent treatment for primary bone sarcoma in the hip/pelvic region. A qualitative, phenomenological, and hermeneutic design was applied. Methods. Sarcoma survivors...

Descripción completa

Detalles Bibliográficos
Autores principales: Fauske, Lena, Bruland, Oyvind S., Grov, Ellen Karine, Bondevik, Hilde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407620/
https://www.ncbi.nlm.nih.gov/pubmed/25949211
http://dx.doi.org/10.1155/2015/484196
_version_ 1782367941714509824
author Fauske, Lena
Bruland, Oyvind S.
Grov, Ellen Karine
Bondevik, Hilde
author_facet Fauske, Lena
Bruland, Oyvind S.
Grov, Ellen Karine
Bondevik, Hilde
author_sort Fauske, Lena
collection PubMed
description Purpose. Our study aims to explore how former cancer patients experience physical and psychosocial late effects 3–7 years after they underwent treatment for primary bone sarcoma in the hip/pelvic region. A qualitative, phenomenological, and hermeneutic design was applied. Methods. Sarcoma survivors (n = 10) previously treated at Oslo University Hospital, Norwegian Radium Hospital were selected to participate. In-depth and semistructured interviews were conducted. The interviews were analysed using inductive thematic analysis. Results. The participants reported that the late effects had three core spheres of impact: “their current daily life,” “their future opportunities,” and “their identity.” They expressed negative changes in activity, increased dependence on others, and exclusion from participation in different areas. Their daily life, work, sports activities, and social life were all affected. Several of their experiences are similar to those described by people with functional impairment or disability. Conclusion. Patients cured of bone cancer in the hip/pelvic region pay a significant price in terms of functional impairment, practical challenges, exclusion from important aspects of life, and loss of previous identity. It is important to appreciate this in order to help bone cancer survivors who struggle to reorient their life and build a secure new identity.
format Online
Article
Text
id pubmed-4407620
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-44076202015-05-06 Cured of Primary Bone Cancer, But at What Cost: A Qualitative Study of Functional Impairment and Lost Opportunities Fauske, Lena Bruland, Oyvind S. Grov, Ellen Karine Bondevik, Hilde Sarcoma Research Article Purpose. Our study aims to explore how former cancer patients experience physical and psychosocial late effects 3–7 years after they underwent treatment for primary bone sarcoma in the hip/pelvic region. A qualitative, phenomenological, and hermeneutic design was applied. Methods. Sarcoma survivors (n = 10) previously treated at Oslo University Hospital, Norwegian Radium Hospital were selected to participate. In-depth and semistructured interviews were conducted. The interviews were analysed using inductive thematic analysis. Results. The participants reported that the late effects had three core spheres of impact: “their current daily life,” “their future opportunities,” and “their identity.” They expressed negative changes in activity, increased dependence on others, and exclusion from participation in different areas. Their daily life, work, sports activities, and social life were all affected. Several of their experiences are similar to those described by people with functional impairment or disability. Conclusion. Patients cured of bone cancer in the hip/pelvic region pay a significant price in terms of functional impairment, practical challenges, exclusion from important aspects of life, and loss of previous identity. It is important to appreciate this in order to help bone cancer survivors who struggle to reorient their life and build a secure new identity. Hindawi Publishing Corporation 2015 2015-04-09 /pmc/articles/PMC4407620/ /pubmed/25949211 http://dx.doi.org/10.1155/2015/484196 Text en Copyright © 2015 Lena Fauske et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Fauske, Lena
Bruland, Oyvind S.
Grov, Ellen Karine
Bondevik, Hilde
Cured of Primary Bone Cancer, But at What Cost: A Qualitative Study of Functional Impairment and Lost Opportunities
title Cured of Primary Bone Cancer, But at What Cost: A Qualitative Study of Functional Impairment and Lost Opportunities
title_full Cured of Primary Bone Cancer, But at What Cost: A Qualitative Study of Functional Impairment and Lost Opportunities
title_fullStr Cured of Primary Bone Cancer, But at What Cost: A Qualitative Study of Functional Impairment and Lost Opportunities
title_full_unstemmed Cured of Primary Bone Cancer, But at What Cost: A Qualitative Study of Functional Impairment and Lost Opportunities
title_short Cured of Primary Bone Cancer, But at What Cost: A Qualitative Study of Functional Impairment and Lost Opportunities
title_sort cured of primary bone cancer, but at what cost: a qualitative study of functional impairment and lost opportunities
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407620/
https://www.ncbi.nlm.nih.gov/pubmed/25949211
http://dx.doi.org/10.1155/2015/484196
work_keys_str_mv AT fauskelena curedofprimarybonecancerbutatwhatcostaqualitativestudyoffunctionalimpairmentandlostopportunities
AT brulandoyvinds curedofprimarybonecancerbutatwhatcostaqualitativestudyoffunctionalimpairmentandlostopportunities
AT grovellenkarine curedofprimarybonecancerbutatwhatcostaqualitativestudyoffunctionalimpairmentandlostopportunities
AT bondevikhilde curedofprimarybonecancerbutatwhatcostaqualitativestudyoffunctionalimpairmentandlostopportunities